Device closure of muscular ventricular septal defects using the Amplatzer muscular ventricular septal defect occluder: Immediate and mid-term results of a U.S. registry
Ralf J. Holzer,David T. Balzer,Qi-Ling Cao,Ken Lock,Ziyad M. Hijazi,Amplatzer Muscular Ventricular Septal Defect Investigators +5 more
351
TL;DR: The Amplatzer mVSD device (AGA Medical Corp.) offers excellent closure rates and low mortality when used to close congenital muscular VSDs.
read more
About: This article is published in Journal of the American College of Cardiology. The article was published on 07 Apr 2004. and is currently open access. The article focuses on the topics: Heart septal defect.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Medium to long-term echo follow-up after ventricular septal defect device closure.
TL;DR: Transcatheter closure of perimembranous and muscular ventricular septal defects is effective, however, these patients need to be followed up regularly to detect device-related problems, specifically, aortic and tricuspid valve regurgitation.
Antegrade Percutaneous Closure of Membranous Ventricular Septal Defect Using X-Ray Fused With Magnetic Resonance Imaging
Kanishka Ratnayaka,Venkatesh K. Raman,Anthony Z. Faranesh,Merdim Sonmez,Merdim Sonmez,Merdim Sonmez,June Hong Kim,Luis F. Gutiérrez,Cengizhan Ozturk,Cengizhan Ozturk,Elliot R. McVeigh,Michael C. Slack,Michael C. Slack,Robert J. Lederman +13 more
TL;DR: XFM facilitates antegrade access to membranous VSD from the right ventricle in swine, and the simplified procedure is faster and reduces radiation exposure compared with the conventional retrograde approach.
Transcatheter device versus surgical closure of ventricular septal defects: a clinical decision analysis.
TL;DR: When outcomes and their values are considered in a systematic manner, transcatheter device closure of suitable VSDs is favored over surgical repair.
Transcatheter Closure of Postoperative Residual Perimembranous Ventricular Septal Defects
TL;DR: Transcatheter closure of postoperative residual perimembranous ventricular septal defect (PmVSD) is possible without the need for reoperation and the early and midterm prognosis of patients with transcatheterclosure is good.
References
Transcatheter closure of ventricular septal defects.
TL;DR: Preliminary data indicate that transcatheter VSD closure is feasible in selected cases, and three congenital VSDs had absent or diminished shunts after umbrella closure.
484
Echocardiographic follow-up of atrial septal defect after catheter closure by double-umbrella device.
Christine Boutin,Norman N. Musewe,Jeffrey F. Smallhorn,John Dyck,T Kobayashi,Leland N. Benson +5 more
TL;DR: It is suggested that ongoing spontaneous resolution of residual shunting occurs after device insertion, and factors related to the defect or device could not predict eventual resolution of remnant shunting.
206
Perventricular device closure of muscular ventricular septal defects on the beating heart: technique and results.
TL;DR: Perventricular closure of multiple muscular ventricular septal defects is safe and effective and could become the treatment of choice for any infant with muscular Ventricle free wall defects or any child with muscular ventricle sePTal defect and associated cardiac defects.
177
Transcatheter closure of muscular ventricular septal defects with the amplatzer ventricular septal defect occluder: initial clinical applications in children.
TL;DR: This encouraging initial clinical success indicates that the AVSDO is a promising device for transcatheter closure of MVSDs in children, and further clinical trials and longer follow-up are needed before the widespread use of this technique can be recommended.
173
Transcatheter closure of single muscular ventricular septal defects using the Amplatzer muscular VSD occluder: Initial results and technical considerations
TL;DR: The Amplatzer MVSD occluder is a safe and effective device for closure of MVSDs up to 12 mm in diameter and further clinical trials with this device are underway.
172
Related Papers (5)
[...]